Abstract
Although the public perception of micro-organisms may be one of disease-causing germs, biotechnology is generally regarded as being a very safe industry with no reported cases of worker mortality caused by exposure to micro-organisms or their products. However, there have been many cases of workers being removed from processes or even from a company because of illness due to exposure to a micro-organism or a microbial product. Instances of occupational respiratory allergies have been reported in many countries including Britain, the former Soviet Union, the United States, the former Czechoslovakia, Italy and China.1. There are European biotechnology companies who have incidences of occupational asthma in the workforce of 12% with the resulting problem of losing highly qualified staff. In the UK occupational asthma caused by some biological products, including antibiotics and proteases, is recognised as a compensatable illness. Expenditure on preventing these symptoms is economic since it reduces sick leave, compensation and re-training costs.2.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bennett, A.M. and Norris, (1988). Evaluation of Hazards From Exposure to Microorganisms and Their Products. State of the Art report 2, Industrial Biosafety Project, Warren Spring Laboratory, Stevenage, UK.
Health and Safety Executive (1991). Medical Aspects of Occupational Asthma. Guidance Note MS25. HMSO.
Rimmington, A. (1988). The Release of Microorganisms and Other Pollutants From Soviet Microbiological Facilities. The Political and Environmental Fall-out. Department of Soviet Studies, University of Birmingham.
Rimmington, A. (1990). On the Russian front: Soviet plans to expand lysine production hit by environmental protest, Genetic Engineer and Biotechnologist. May/June, 5.
Commission of the European Community (1988). Proposal for a council directive on the protection of workers from the risks related to exposure to biological agents at work, Official Journal of the European Communities. C 150/6–14, 8 June.
Commission of the European Community (1990a). Directive on the Contained Use of Genetically-Modified Organisms. 90/219/EEC, 23.04.90 (OJ L177, 08.05.90). CEC, Brussels.
Commission of the European Community (1990b). Directive on the Deliberate Release into the Environment of Genetically-Modified Organisms. 90/220/EEC, 23.04.90 (OJ L177, 08.05.90). CEC, Brussels.
Fredtoft, E., Hansen, E. and Johnsen, K. (1990). Experimental gene technology at secondary schools in Denmark. In Proceedings of the 5th European Congress On Biotechnology, pp. 354–357.
Phillips, G.B. (1965). Causal factors in microbiological laboratory accidents and infections, Miscellaneous Publications, 2, Fort Detrick, Maryland, US Biological Laboratory.
Pike, R.M. (1979). Laboratory-associated infections: Incidence, fatalities, causes and prevention, Annual Reviews in Microbiology, 33, 43–56.
Grist, N.R. and Emslie, J.A.N. (1989). Infections in British clinical laboratories, Journal of Clinical Pathology, 42, 677–681.
Collins, C.H. (1987). Laboratory-acquired Infections. Butterworths: London.
Muller, H.E. (1988). Laboratory-acquired mycobacterial infection, Lancet, 2, 311.
Harrington, J.M. (1982). Health and safety in medical laboratories, Bulletin of the World Health Organisation, 60, 9–16.
Anon (1966). Deliberate spreading of typhoid in Japan, Science Journal, October, pp. 11–12.
Blaser, M.J. and Lofgren, J.P. (1981). Fatal Salmonellosis originating in a clinical microbiological laboratory, Journal of Clinical Microbiology, 13, 855–858.
Meeker, D.P., Gephardt, G.N., Cordasco, E.M. and Wiedemann, H.P. (1991). Hypersensitivity pneumonitis versus invasive pulmonary aspergillosis: Two cases with unusual pathologic findings and review of the literature, American Review of Respiratory Disease, 143, 431–136.
Seaton, A. (1991). Invasive pulmonary aspergillosis in non-immunocompromised patients, British Medical Journal, 302, 906.
Israeli, E. (1986). Biosafety in biotechnology processes, Advances in Biotechnology Processes, 6, 1–20.
Schlech, W.F., Turchik, J.B., Westlake, R.E., Klein, G.C., Band, J.D. and Weaver, R.E. (1981). Laboratory-acquired infection with Pseudomonaspseudomallei (melidiosis), New England Journal of Medicine, 305, 1133–1135.
Flindt, M.H.L. (1970). Allergy to a-amylase and papain, Lancet (i), 1407–1408.
Flindt, M.H.L. (1969). Pulmonary disease due to the inhalation of derivatives of Bacillus subtilis containing proteolytic enzyme, Lancet, (i), 1177–1180.
Pepys, J., Hargreaves, F.E., Longbottom, J.L. and Faux J. (1969). Allergic reactions of the lungs to enzymes of Bacillus subtilis, Lancet, (i), 1181–1184.
Greenberg, M., Milne, J.F. and Watt, A. (1970). A survey of workers exposed to dusts containing derivatives of Bacillus subtilis, British Medical Journal, 629.
Newhouse, M.L., Tagg, B., Pocock, S.J. and MacEwan, A.C. (1970). An epidemiological study of workers producing enzyme washing powder, Lancet, (i), 689–693.
Juniper, CP., How, M.J., Goodwin, B.F.G. and Kinshott, A.F. (1977). Bacillus subtilis enzymes: A seven-year clinical, epidemiological and immunological study of an industrial allergen, Journal of the Society of Occupational Medicine, 27, 3–12.
Soap and Detergent Industry Association (1973). The Standing Committee on Enzymatic Washing Powders. Fourth report, April.
Davies, R.J., Hendrick, D.J. and Pepys, J. (1974). Asthma due to chemical agents: ampicillin, 6 amino penicillanic acid and related substances, Clinical Allergy, 4, 227–247.
Baur, X., Fruhman, G., Haug, B., Rasche, B., Reiher, W. and Weiss, W. (1986). Role of Apergillus amylase in baker’s asthma, Lancet, (i), 43.
Losada, E., Hinojosa, M., Moneo, I., Dominguez, J., Gomez, M.L.D. and Ibanez, M.D. (1986). Occupational asthma caused by cellulase, Journal of Allergy and Clinical Immunology, 77, 636–639.
Coutts, I.I., Dally, M.B., Newman Taylor, A.J. and Pickering C.A.C. (1981). Asthma in workers manufacturing cephalosporins, British Medical Journal, 283, 950.
Zachariae, H., Hoegh-Thomsen, J., Witmeur, O. and Wide, L. (1981). Detergent enzymes and occupational safety, Allergy, 36, 513–516.
Maroni, M., Colombi, A., Alcini, D. and Foa V. (1987). Health risks in the biotechnology industry, La Medicina Del Lavora., 78, 272–282 (in Italian).
Brooks, S.M. (1977). Bronchial asthma of occupational origin, Scandinavian Journal of Work Environment and Health, 3, 53–72.
Dunn, M.S. (1968). Allergic disease in industry. In Dangerous Properties of Industrial Materials. (N. Irving Sax, ed.) pp. 257–276.
Lagier, F., Cartier, A., Dolovich J. and Malo, J.-L. (1989). Occupational asthma in a pharmaceutical worker exposed to penicillamine, Thorax, 44, 157–158.
Biryukov, V.V. (1990). Single cell protein — from basic research to production. In Proceeding of the 5th European Congress on Biotechnology, pp. 748–753.
Harris-Smith, R. and Evans, C.G.T. (1974). Bioengineering and protection during hazardous microbiological processes, Biotechnology and Bioengineering Symposium, 4, 837–855.
Topping, M.D., Scarisbrick, D.A., Luczynska, C.M., Clarke, E.C. and Seaton A. (1985). Clinical and immunological reaction to Aspergillus niger among workers at a biotechnological plant, British Journal of Industrial Medicine, 42, 312–318.
Horejsi, M., Sach, J., Tomasikova, A., Mecl, A., Blahnikova, D., Tumova, M. and Valisova, A. (1960). A syndrome resembling farmer’s lung in workers inhaling spores of Aspergillus and Penicillia molds, Thorax, 15, 212–217.
Lacey, J., Pepys, J. and Cross, T. (1972). Actinomycetes and fungus spores in air as respiratory allergens, Society of Applied Bacteriology Technical Series, 6, 151–184.
Fisher, R. and Rosner, L. (1959). Toxicology of the microbial insecticide, Thuricide, Agricultural and Food Chemistry, 7, 686–688.
Kleyn, J.G., Johnson, W.M. and Wetzler, T.F. (1981). Microbial aerosols and Actinomycetes in etiological considerations of mushroom workers lungs, Applied and Environmental Microbiology, 41, 1454–1460.
Lacey, J. (1988). Actinomycetes as causes of lung disease. In Actinomycetes in Biotechnology (Goodfellow, M., Williams, S.T. and Mordarski, M. eds). Academic Press, pp. 406–410.
Woodard, E.D., Friedlander, B., Lesher, R.J., Font, W., Kinsey, R. and Hearne, F.T. (1988). Outbreak of hypersensitivity pneumonitis in an industrial setting, Journal of the American Medical Association, 259, 1965–1969.
Johnson, C.L., Bernstein, I.L., Gallagher, J.S., Bonventre, P.F. and Brooks, S.M. (1980). Familial hypersensitivity pneumonia induced by Bacillus subtilis, American Review of Respiratory Disease, 122, 339–348.
Rimmington, A. (1990). The production and use of microbial pesticides in the USSR. International Industrial Biotechnology, 9, 5–14.
Lacey, J. (1989). Airborne micro-organisms in the work environment, Occupational Health Review, February/March, pp. 20–22.
Cotes, J.E. and Steel J. (1987). Extrinsic allergic alveolitis. In Work-related Lung Disorders, Blackwells, pp. 320–344.
Zhicheng, S. and Pangcheng, L. (1986). Occupational mycoses, British Journal of Industrial Medicine, 43, 500–501.
Kabir, S., Rosenstreich, D.L. and Mergenhagen, S. (1978). Bacterial endotoxins and cell membranes. In Bacterial Toxins and Cell Membranes (Jeljaszewicz, J. and Wadstrom, T. eds) Academic Press: New York, pp. 59–87.
Burrell, R., Lantz, R.C. and Hinton, D.E. (1988). Mediators of pulmonary injury induced by inhalation of bacterial endotoxin, American Review of Respiratory Diseases, 137, 100–105.
Attwood, P., Versloot, P., Heederik, D., de Wit, R. and Boleij, J.S.M. (1986). Assessment of dust and endotoxin levels in the working environment of Dutch pig farmers. A preliminary study, Annals of Occupational Hygiene, 30, 201–208.
Castellan, R.M., Olenchock, S.M., Kinsley, K.B. and Hankinson, J.L. (1987). Inhaled endotoxin and decreased Spirometrie values — an exposure-response relation for cotton dust, New England Journal of Medicine, 317, 605–610.
Kennedy, S.M., Christiani, D.C., Eisen, E.A., Wegman, D.H., Greaves, I.A., Olenchock, S.A., Ye, T.-T. and Lu, P.-L. (1987). Cotton dust and endotoxin exposure-response relationships in cotton textile workers, American Review of Respiratory Disease, 135, 194–200.
Paine, T.F. (1946). Illness in man following inhalation of Serratia marcescens, Journal of Infectious Disease, 79, 226–232.
Ekenvall, L., Dolling, B., Gothe, C.-J., Ebbinghaus, L., Von Stedingk, L. and Wasserman, J.M. (1983). Single cell protein as an occupational hazard, British Journal of Industrial Medicine, 40, 212–215.
Mayes, R.W. (1982). Lack of allergic reaction in workers exposed to Pruteen (bacterial single-cell protein), British Journal of Industrial Medicine, 39, 183–186.
Dunnil, P. (1982). Biosafety in the large scale isolation of intracellular microbial enzymes, Chemistry and Industry, 877–879.
Palchak, R.B., Cohen, R. and Jaugstetter, J. (1990). A threshold limit value for airborne endotoxin associated with industrial-scale production of proteins in Gram-negative bacteria, Developments in Industrial Microbiology, 31, 199–203.
Elissalde, M.H. and Beier, R.C. (1990). Stimulation and release of prostaglandins and thromboxane from macrophages by cotton dust associated lipopolysaccharides, American Industrial Hygiene Association Journal, 51, 652–658.
Rylander, R., Haglind, H., Lundholm, M., Mattsby, I. and Stenquist, K. (1978). Humidifier fever and endotoxin exposure, Clinical Allergy, 8, 511–516.
Poller, L., Thomson, J.M., Otteridge, B.W., Yee, K.F. and Logan, S.H.M. (1979). Effects on manufacturing oral contraceptives on blood clotting, British Medical Journal, 1, 1761–1762.
Willems, H. (1981). Occupational exposure to estrogen and screening for health effects, Journal of Occupational Medicine, 23, 813–816.
Baxter, P.J., Samuel, A.M., Aw, T.C. and Cocker J. (1986). Exposure to quinal-barbitone in pharmaceutical workers, British Medical Journal, 292, 660–661.
Farina, G., Alessio, L. and Bulgheroni, C. (1980). Occupational exposure to drugs — antibiotics, La Medicina Del Farmaci, 3, 228–234.
Sargeant, K. and Evans, C.G.T. (1979). Hazards Involved in the Industrial Use of Microorganisms. Office for Official Publications of the European Community, Luxembourg.
Sorenson, W.G. (1990). Mycotoxins as potential occupational hazards, Developments In Industrial Microbiology, 31, 205–211.
Wheale, P. and McNally, R. (1988). Genetic Engineering: Catastrophe or Utopia, Harvester, Wheatsheaf, England, pp. xv–xvi.
Jukes, T.H. (1988). Hazards of biotechnology: facts and fancy, Journal of Chemical Technology and Biotechnology, 43, 1–11.
Anon (1990). “A yeast release” A genetic engineering first for the food industry, Genetic Engineer and Biotechnologist, May/June, 24–25.
Frommer, W., Archer, L., Boon, B. et al. (1993). Safe biotechnology (5). Recommendations for safe work with animal and human cell cultures concerning potential human pathogens, Applied Microbiology and Biotechnology, 39, 141–147.
Bennett, A.M., Hill, S.E., Benbough, J.E. and Hambleton, P. (1991). Monitoring safety in process biotechnology, in Genetic Manipulation: Techniques and Application. The Society of Bacteriology Technical Series; no. 28 (Grange, J.M., Fox, A. and Morgan, N.L. eds), pp. 363-376.
Ashcroft, J. and Pomeroy, N.P. (1983). The generation of aerosols which may occur during plant scale production of microorganisms, Journal of Hygiene, 91, 81–91.
Harper, G.J. (1984). Evaluation of sealed containers for use in centrifuges by a dynamic microbiological test method, Journal of Clinical Pathology, 37, 1134–1139.
Wickramanayake, G.B. (1987). Assessment of Decontamination Technologies for Release from Large-scale r-DNA Processing Facilities. Batelle report commissioned by the US Environmental Protection Agency.
Dimmick, R.L., Vogl, W.F. and Chatigny, M.A. (1973). Potential for accidental microbial aerosol transmission in the biological laboratory. In Biohazards in Biological Research (Hellman, A., Oxman, M.N. and Pollack, R. eds). Cold Spring Harbor Laboratory, New York, pp. 246–256.
Chatigny, M.A. and Pruisner, S.B. (1980). Biohazards of investigations on transmissable spongiform encephalopathies, Review of Infectious Disease, 2, 713–724.
Ager, B.P. and Nourish, R. (1988). UK regulations and guide-lines for genetic manipulation, Journal of Chemical Technology and Biotechnology, 43, 109–117.
Health and Safety Executive (1991). Occupational Lung Disease: A Guide to Employers. MS(B)16 C200 8/91.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Bennett, A.M. (1994). Health hazards in biotechnology. In: Hambleton, P., Melling, J., Salusbury, T.T. (eds) Biosafety in Industrial Biotechnology. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-1352-6_7
Download citation
DOI: https://doi.org/10.1007/978-94-011-1352-6_7
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-4590-2
Online ISBN: 978-94-011-1352-6
eBook Packages: Springer Book Archive